Metraipolis › archive › dc_4a449cb2b37d

Current status on encephalitic alphavirus vaccines development: Advances, challenges, and global health perspectives — Europe PMC PMID:42004740

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42004740
DOI
10.1016/j.imj.2026.100249
License (as archived)
solo-consultazione
Archived
2026-11-04T01:40:26.992Z
SHA-256 of the archived text
1d2ec6ce76492bdf6a3bce7ca9c51b913d674786cf7b973255fed783533819d3
Stable URL of this page
https://metraipolis.com/documento/dc_4a449cb2b37d

How to cite

Current status on encephalitic alphavirus vaccines development: Advances, challenges, and global health perspectives — Europe PMC PMID:42004740 — Europe PMC (en), https://europepmc.org/article/MED/42004740 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a449cb2b37d (Metraipolis archive dc_4a449cb2b37d, sha256 1d2ec6ce76492bdf6a3bce7ca9c51b913d674786cf7b973255fed783533819d3)
BibTeX
@misc{dc4a449cb2b37d,
  title = {Current status on encephalitic alphavirus vaccines development: Advances, challenges, and global health perspectives — Europe PMC PMID:42004740},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42004740},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a449cb2b37d; sha256 1d2ec6ce76492bdf6a3bce7ca9c51b913d674786cf7b973255fed783533819d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42004740. Agents can read the archived copy with the MCP tool read_document.